Bigul

Sigachi Industries Ltd - 543389 - Board declares Interim Dividend

Sigachi Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 22, 2022, inter alia, has approved the following :- Declaration of Interim dividend of 10% i.e. Re. 1/- per equity share of Rs. 10/- each. Further, the Board noted that payment of Final Dividend for 2021-22 was honest an honest omission due to oversight. Therefore, towards its continuous commitment to Investors, the Board has declared Interim Dividend as a compensation for Final Dividend for FY 2021-22.
22-07-2022
Bigul

Sigachi Industries Ltd - 543389 - Statement Of Deviation / Variation In Utilization Of Funds Raised In IPO

Statement of Deviation / Variation in utilization of funds raised in IPO
22-07-2022
Bigul

Sigachi Industries Ltd - 543389 - Board Meeting Intimation for Quarterly Results, Dividend, AGM, And Other Business Related Matters

Sigachi Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2022 ,inter alia, to consider and approve Quarterly Results, Dividend, AGM Notice, and other business related matters
15-07-2022
Bigul

Sigachi Industries Ltd - 543389 - Statement Of Investor Complaints For The Quarter Ended June 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Shreya MitraDesignation :- Company Secretary and Compliance Officer
12-07-2022
Bigul

Sigachi Industries Ltd - 543389 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate of Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for Quarter ended June 30, 2022
12-07-2022
Bigul

Sigachi Industries Ltd - 543389 - Expansion Of Company''s Business Line Into Human Nutritional Segment

Expansion of company''s business line into Human Nutritional Segment
03-07-2022
Next Page
Close

Let's Open Free Demat Account